The document discusses the role of family physicians in controlling chronic kidney disease (CKD) in India. It notes that while infections are decreasing, non-communicable diseases like diabetes and hypertension that can lead to CKD are increasing. CKD prevalence in India is estimated at 11-15% but awareness remains low. Family physicians can play a key role in early detection through regular screening of at-risk groups and monitoring of creatinine levels and protein in urine. Lifestyle modifications like diet, exercise, and controlling diabetes and hypertension are emphasized. Close coordination between family physicians and nephrologists from early stages of CKD is important for optimal care.
Diabetic nephropathy considered one of the most common complications of DM. This presentation answer the question are some diabetic patient immune to diabetic nephroapthy
MANAGEMENT OF DIABETES IN CHRONIC KIDNEY DISEASE (Special reference to Use of...Dr. Om J Lakhani
Talk on MANAGEMENT OF DIABETES IN CHRONIC KIDNEY DISEASE (Special reference to Use of Metformin In CKD).
Presented on 25th June 2017 at THE METFORMIN MEET in Vadodara, India
Diabetic nephropathy considered one of the most common complications of DM. This presentation answer the question are some diabetic patient immune to diabetic nephroapthy
MANAGEMENT OF DIABETES IN CHRONIC KIDNEY DISEASE (Special reference to Use of...Dr. Om J Lakhani
Talk on MANAGEMENT OF DIABETES IN CHRONIC KIDNEY DISEASE (Special reference to Use of Metformin In CKD).
Presented on 25th June 2017 at THE METFORMIN MEET in Vadodara, India
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
The Gram stain is a fundamental technique in microbiology used to classify bacteria based on their cell wall structure. It provides a quick and simple method to distinguish between Gram-positive and Gram-negative bacteria, which have different susceptibilities to antibiotics
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAkankshaAshtankar
MIP 201T & MPH 202T
ADVANCED BIOPHARMACEUTICS & PHARMACOKINETICS : UNIT 5
APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS By - AKANKSHA ASHTANKAR
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
1. D E P T. O F M E D I C I N E ,
B H A R AT I H O S PI TA L A N D R E S E A RC H C E N T R E ,
PU N E .
Role of Family Physician in the
control of chronic kidney
disease(CKD).
2. Problem statement.
India is moving ahead in all fronts, especially in the
field of healthcare and in particular medicine.
The last few decades have seen an increasing number
of infections get under control.
There is however an increase in the number of non-
communicable diseases like DM, HTN,
Cardiovascular diseases, strokes to name a few. All of
these are eventually associated with co-morbiditiies
such as CKD.
Data suggests that around 11-15% of the general
population has CKD.
4. Contributors to the problem
Awareness of kidney diseases is relatively low in our
community including among us doctors and
healthcare workers.
Sr. Creatinine level, though widely advised and easily
available, is a poor marker of renal function.
Most patients are asymptomatic to begin with. This
is why they do not approach a doctor in the early
stages of the disease.
5. What is Chronic Kidney Disease(CKD)?
CKD is an all inclusive term:
The chief criteria are:
Glomerular filtration rate(GFR) < 60 ml/min for >
months.
Complains of persistent renal damage by pathological or
imaging tests even in presence of a normal GFR.
6. Why is it CKD and not Chronic Renal Failure (CRF)?
The spectrum of the patient’s condition ranges from
being asymptomatic to being dialysis dependent.
The term “kidney” is better understood by the lay
people.
As mentioned earlier, Sr. Creatinine is not a reliable
marker for assessing renal function; particularly in
the elderly.
The gold standard test for this purpose remains GFR.
7. GFR: The Gold Standard.
Defintion:A kidney function test in which results are
determined from the amount of ultrafiltrate formed by
plasma flowing through the glomeruli of the kidney. The
amount is calculated from inulin and creatinine clearance,
serum creatinine, and blood urea nitrogen.
A number of formulae have been developed for GFR
estimation. These include.
Cockcroft-Gault formula.
Schwartz formula
Mayo Quadratic formula
CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) formula
Modification of Diet in Renal Disease (MDRD) formula
8. The most commonly employed formula is the Cockcroft-
Gault formula:
A commonly used surrogate marker for estimate of creatinine
clearance (eCCr) is the Cockcroft-Gault formula, which in turn
estimates GFR in ml/min.
(eCCr :- Estimated creatinine clearance rate)
9. Evolution of CKD
The disease progresses through 5 stages with
progressive decline in renal function as assessed by
GFR. Out of these:
Stages 1 and 2 are asymptomatic.
Stages 3 to 5 correspond to CRF ( GFR < 60 ml/min)
Stage 5 is also known as End Stage Renal Disease(ESRD)
where the GFR falls to below < 15 ml/min.
At ESRD the treatment modalities available to the patient
include DIALYSIS or RENAL TRANSPLANT.
10. Identifying the vunerable population.
Regular screening for renal function must be done
especially for the subset of population which is at
risk. This includes:
Elderly people, diabetics, hypertensives.
Those with malignancy, autoimmune disease.
Renal stones
Recurrent UTI, family H/O CKD
Low birth weight, reduced kidney mass
Obese people, smokers.
Users of Non Steroidal Anti-inflammatory Drugs(NSAIDs).
Young hypertensives.
11. Role of the Doctor
A nephrologist has a rather limited role in the early
diagnosis of CKD.
A family physician is more substantial in the initial
stages. He should develop a high suspicion index for
renal disorders amongst his patients and look for
decline of renal function. He can do this by:
Looking for protienuria atleast annually
Sr. Creatinine
USG (A+P)- for stones, cysts, hydronephrosis.
12. Advice on Lifestyle modification
Pt. should target an ideal body weight, exercise
regularly, stop smoking, reduce stress.
Diet: diet rich in fruits and vegetables are best for
health in presence of normal renal function.
In CKD stages 3 to 5 however these can be dangerous as they
increase Sr. Potassium. This can be overcome by leaching of
the vegetable.
Curtail salt intake to 3-4 gm/day.
Intake-output must be monitored
Proteins 0.69gm/kg of high biological value.
13. Routine chek up for all.
Check up for even the healthy population must be
advocated.
Every adult must have atleast a Blood Pressure
check annually.
Out of this the at risk population must be identified
and screened.
14. Lab tests:
Urine examination:
Routine:Simple dipstick for proteinuria in the clinic
Ideal: the Micral test to look for Microalbuminuria particularly
in the diabetic pateint.
Microscopy: casts, RBC’s.
• GFR calculation (using Sr. Creatinine)
15. DM and HTN: Main constituents of the pool.
Optimal control of BSL:
Diabetics form 40% of dialysis patients.
HbA1c < 7% must be targeted in this population.
Blood pressure control : <130/80 mm of Hg
Use the combination of correct drugs
Correct usage of renoprotective agents like ACE Inhibitors and
ARB’s
Monitoring RFT’s and Sr. Electrolytes while giving these
agents.
16. Avoiding the pitfalls:
Advise regarding avoidance of usage of NSAIDs on a
long term basis even for chronic inflammatory
conditions.
COX -2 Inhibitors
Treatment of co-morbidities should be thorough.
Since the Risk of coronary events and strokes increases drugs
such as Statins and low dose aspirin should be prescribed as
needed.
17. Interaction between the physician and the nephrologist.
An early referral should be done when the creatinine
level is borderline for establishing the etiology and
for treating a correctable cause.
Patient should follow up with the family physician
regularly.
Parameters such as BP and haemoglobin levels
(between 11-12 g/dl) should be monitored.
Avoidance of nephrotoxic drugs.
Regular monitoring of renal and other parameters
initially- 3 monthly.
Transplant and dialysis education.
18. Take Home Message
India is increasingly becoming renowned as the
Chronic Kidney Disease and Diabetic Capital
An integrated approach in addition to increased
patient awareness through education can help tame
this modern epidemic.